3 ms·
Unfortunately not really, because the infrastructure that allows us to glean insights from actual healthcare practices is abysmal/nonexistent, at least in the U
by ethanbond 3y ago
Unfortunately not really, because the infrastructure that allows us to glean insights from actual healthcare practices is abysmal/nonexistent, at least in the US.
It became clear during COVID that a lot of people seem to presume there's some way for researchers to just "look at what's happening," and there isn't.
- nradov 3y agoThere's no nationwide research infrastructure for gleaning insights like that. But large provider organizations have huge patient populations and do a lot of research. They have multiple studies underway for Ozempic and similar drugs.
- seanp2k2 3y agoClinical research trials are a lot more useful as they get a lot more data points from far fewer patients. Not many people want to get blood drawn every week and keep a detailed daily journal about eating and exercise habits.
- ethanbond 3y agoTotally. I didn’t say “it won’t be studied,” I’m saying the data won’t be “great,” as described above.
- anigbrowl 3y agoThat's a really good point, and it seems to pervade the scientific establishment. There's an unfortunate tendency to study something, and (assuming a real effect is found & reproduced) say 'well we know about that now' and just move onto something else, instead of building out infrastructure to gather more longitudinal/geographic data. The efforts in the UK to build huge datasets for long-term diagnostics is a welcome exception.